Article
Generation of two iPSC lines from hypertrophic cardiomyopathy patients carrying MYBPC3 and PRKAG2 variants.
Stem cell research - 1 May 2022
Manhas Amit, Jahng James W S, Vera Carlos D, Shenoy Sushma P, Knowles Joshua W, Wu Joseph C
Abstract excerpt
Hypertrophic cardiomyopathy (HCM) is an inherited cardiac disorder characterized by a thick left ventricular wall and an increased risk of arrhythmias, heart failure, and sudden cardiac death. The MYBPC3 and PRAKG2 are known causal genes for HCM. Here we generated two human-induced pluripotent stem cell lines from two HCM patients carrying two heterozygous mutations in MYBPC3 (c.459delC) and PRKAG2 (c.1703C > T)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
